What is Particles for Humanity?
Particles for Humanity operates at the intersection of high-tech medical innovation and humanitarian aid. The company specializes in developing affordable, scalable technologies designed to mitigate health disparities in underserved regions. A cornerstone of their product portfolio is the PFH-VAP technology, which enhances the stability of vitamin A for food fortification, a critical intervention for improving nutritional outcomes in vulnerable communities. By focusing on low-cost, high-impact solutions, the company effectively addresses systemic health challenges that traditional market-driven entities often overlook. Their market position is defined by a unique blend of rigorous scientific research and a deep-seated commitment to social equity, making them a key player in the global health technology landscape.
How much funding has Particles for Humanity raised?
Particles for Humanity has raised a total of $19M across 3 funding rounds:
Grant
$5M
Unspecified
$4M
Grant
$10M
Grant (2020): $5M with participation from Bill & Melinda Gates Foundation
Unspecified (2022): $4M led by Bill & Melinda Gates Foundation, King Philanthropies, and Mulago Foundation
Grant (2023): $10M supported by Bill & Melinda Gates Foundation
Key Investors in Particles for Humanity
Bill & Melinda Gates Foundation
Established in 2000 and headquartered in Seattle, Washington, The Bill & Melinda Gates Foundation is an organization that focuses on supporting individuals experiencing hunger and extreme poverty in leading healthier lives.
King Philanthropies
King Philanthropies is dedicated to making a significant impact on the lives of the world's poorest individuals by enhancing the effectiveness of high-performing leaders and organizations while addressing barriers to economic development.
Mulago Foundation
Mulago Foundation identifies scalable ideas and supports founders who can drive them to success, focusing on funding and teaching individuals with innovative solutions to poverty across various sectors.
What's next for Particles for Humanity?
With the recent capital injection, Particles for Humanity is poised to transition into a phase of expanded operational capacity and product distribution. The strategic focus will likely shift toward scaling the manufacturing and implementation of their core technologies, particularly in regions where nutritional and medical infrastructure remains underdeveloped. Future growth will be predicated on the company's ability to maintain its cost-efficiency while navigating the complex regulatory and logistical environments of emerging markets. As the firm continues to attract high-profile philanthropic backing, it is expected to deepen its research pipeline, potentially introducing new interventions that address a broader spectrum of preventable health conditions. The emphasis will remain on achieving exponential impact through data-driven, sustainable solutions that empower local health systems.
See full Particles for Humanity company page
